Quantcast

Latest Caphosol Stories

2011-08-09 07:30:00

DALLAS and NEW YORK, Aug. 9, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that Community Specialty Pharmacy Network (CSPN), the 10th-largest network of specialty pharmacies in the U.S., has joined its specialty pharmacy network for MuGard, its lead product for oral mucositis. With more than 180 member...

2011-07-28 07:15:00

DALLAS and NEW YORK, July 28, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, has launched its patient reimbursement and support center for its lead product for oral mucositis, MuGard. Referred to as a HUB, the MuGard Patient Reimbursement and Support Center (MuGard PRSC) operated by eMax Health provides a...

2011-07-21 07:15:00

DALLAS and NEW YORK, July 21, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that its lead product for oral mucositis, MuGard, is being covered by Harvard Pilgrim and has been added to its pharmaceutical drug benefit program. Covering over one million lives, Harvard Pilgrim is a premier insurance...

2011-07-13 07:30:00

DALLAS and NEW YORK, July 13, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that it has signed an agreement to restructure the outstanding senior convertible promissory note scheduled to mature this year. The amended agreement provides for extension of 50% of the principal amount of the note until...

2011-05-17 07:00:00

DALLAS and NEW YORK, May 17, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that it had made significant progress with the commercial introduction of MuGard in the radiation oncology and medical oncology communities. MuGard is a novel, ready-to-use mucoadhesive oral wound rinse and coating that has been shown to be...

2011-05-05 00:00:29

Invado Pharmaceuticals announced the completion of a pilot study for NeutraSal® (supersaturated calcium phosphate rinse) in patients experiencing medication-induced xerostomia or dry mouth. NeutraSal® relieved the symptoms of xerostomia in all subjects while also normalizing the pH of the mouth. (PRWEB) May 04, 2011 Invado Pharmaceuticals announced the completion of a pilot study for NeutraSal® (supersaturated calcium phosphate rinse) in patients experiencing medication-induced...

a3d5fcb1aa5698e46744a8142a81e1241
2011-03-24 06:10:00

A NASA technology originally developed for plant growth experiments on space shuttle missions has successfully reduced the painful side effects resulting from chemotherapy and radiation treatment in bone marrow and stem cell transplant patients. In a two-year clinical trial, cancer patients undergoing bone marrow or stem cell transplants were given a far red/near infrared Light Emitting Diode treatment called High Emissivity Aluminiferous Luminescent Substrate, or HEALS, to treat oral...

2011-03-24 00:00:28

Treatment is being developed to reduce oral infection and pain associated with cancer treatments Honolulu, HI and Claremont CA (PRWEB) March 22, 2011 Biotech firm Synedgen announces the award of a competitive Phase II SBIR grant by the National Institutes of Health (NIH) to accelerate the development of Synedgen's proprietary oral disease treatments. Under this 2-year $1.96 M effort, starting on April 1, Synedgen will accelerate the development of RegenasynTM, a topical treatment for oral...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related